-
Global Trends
Instability Signals and New Opportunities in the Rare Cardiovascular Market (ATTR-CM)
The burgeoning field of transthyretin amyloid cardiomyopathy (ATTR-CM)—once projected to become a $20 billion market—may have just revealed the first…
Read More » -
Global Trends
-
Global Trends
Eli Lilly and NVIDIA Announce Partnership to Build Advanced AI Supercomputer
Pharmaceutical giant Eli Lilly and technology firm NVIDIA have disclosed a collaboration to construct a new supercomputing system. The project…
Read More » -
Global Trends
Landmark Trade Agreement Shapes UK-US Pharmaceutical Market
The United Kingdom and the United States have reached a bilateral agreement to maintain zero tariffs on UK pharmaceutical shipments…
Read More » -
Local Dynamics
Noble Gesture Revives 16 Lives in 48 Hours
In just one weekend (November 29 – November 30), a profound humanitarian gesture of organ donation from three brain-dead individuals,…
Read More » -
Local Dynamics
High-Level Personnel Appointment Bolsters Health Trade Union Activities
On December 1, the Vietnam General Confederation of Labour (VGCL) announced a significant personnel decision, appointing Mr. Nguyen Luong Tam,…
Read More » -
Local Dynamics
Strategic Direction Towards Universal Free Healthcare Unveiled
On the afternoon of December 1, the Ministry of Health (MoH) organized a workshop to gather expert opinions on the…
Read More » -
Local Dynamics
Vietnam’s Ministry of Health Expands List of Diseases Under Surveillance
The Ministry of Health (MoH) has issued a Decision adding 12 diseases to the list of Group A and Group…
Read More » -
Local Dynamics
International Scientific Collaboration Advances Infectious Disease Research
A Vietnamese Research Institute has collaborated with Stanford University’s Institute for Microbiology and Epidemiology (US) to implement international-standard Hepatitis D…
Read More » -
Health Ministry Proposes Standardization of Medical Device Selection
The Ministry of Health (MoH) is currently soliciting feedback on a vital Draft Circular. This document provides guidance on classifying…
Read More » -
Wellness
Stress Management for Leaders: A Critical Competency in Modern Leadership
In today’s volatile business environment, leaders must think fast, stay resilient, and make high-stakes decisions with clarity. Stress is no…
Read More » -
Career Oportunities
-
Wellness
Stroke: Pathophysiology – Epidemiology – Emergency Management & Prevention
Abstract Stroke, including ischemic and hemorrhagic types, remains the second leading cause of death and a major cause of long-term…
Read More » -
Global Trends
Sun Pharmaceutical’s updated label for Unloxcyt receives US FDA approval
The U.S. Food and Drug Administration (USFDA) has approved an updated label for Unloxcyt (cosibelimab-ipdl) for the treatment of adults…
Read More » -
Global Trends
Generic Drug Approval Secured for Type 2 Diabetes Treatment in the US
A pharmaceutical company has announced that it secured tentative approval from the United States Food and Drug Administration (USFDA) for…
Read More » -
Global Trends
Major Pharmaceutical Group Acquires Preclinical Cancer Asset
In light of substantial recent investments in oncology and mounting competition, a leading pharmaceutical corporation is seeking a new approach…
Read More » -
Global Trends
Novel Immunotherapy Regimen Approved for Early-Stage Gastric Cancer
The U.S. Food and Drug Administration (FDA) has granted approval for the use of Durvalumab (an immunotherapy) in combination with…
Read More » -
Global Trends
Expedited Review Sought for New Higher-Dose Obesity Treatment
A pharmaceutical corporation has submitted a supplemental application for a higher dose semaglutide injectable (7.2 mg) to the U.S. Food…
Read More » -
Global Trends
Global Strategic Restructuring: A Major Pharma Group’s Shift Toward Automation and Production Reallocation
The recent decisions by a leading Swiss pharmaceutical group highlight a broader trend within the industry: prioritizing automation, advanced manufacturing…
Read More » -
Global Trends
Cost-Effective Solution for Retinal Diseases Enters European Market
On November 24, 2025, in Basel, Sandoz, a global leader in affordable medicines, announced the European launch of Afqlir® (aflibercept).…
Read More »
